Association of protein kinase C zeta polymorphisms with diabetes
US6562574B2 · kind B2 · utility
1Cited by
5References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 25, 2001 |
| Grant date | May 13, 2003 |
| Priority date | — |
| Expiry date | Apr 25, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/156
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A central role for the gene encoding protein kinase C zeta in diabetes and perhaps in related disorders is disclosed. Use of single nucleotide polymorphisms in the protein kinase C zeta gene for diagnosis, prediction of clinical course and treatment response, development of new treatments and development of cell-culture based and animal models for research and treatment are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.